While the number of companies involved in cell therapies worldwide is growing, there are few organisations capable of delivering the necessary combination of skills and expertise to successfully translate such therapies into clinical practice. Contract manufacturers in the cell and tissue space must have an ability to understand and work with both the commercial imperatives of biotech start-ups and a complex regulatory environment. Clients require a multidisciplinary resource that can quickly absorb and master the technical aspects of a therapy and simultaneously provide consulting services or strategic planning that facilitates and synchronises with the commercial imperatives of the business and its target market.

Cell Therapies Pty Ltd is novel, a stand-alone, small company attached to an academic research centre and a primary cancer centre (Peter MacCallum Cancer Centre). Cell Therapies provide seamless, integrated services from the research bench through to the principal investigator; and in parallel manage the interface with the Regulator.

Clinical and Commercial Solutions, the Market and the Regulator - PDF 1.04Mb Clinical_and_Commercial_Solutions.pdf

--------------------------------------------------------------------------------